Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience.
Sign Up to like & getrecommendations! Published in 2019 at "Rheumatology"
DOI: 10.1093/rheumatology/kez267
Abstract: OBJECTIVES To evaluate the efficacy and safety of apremilast in treating oral ulcers (OUs), the cardinal and high-disabling feature of Behçet's disease (BD). METHODS Twelve consecutive patients affected by BD with recurrent/relapsing OUs resistant and/or… read more here.
Keywords: efficacy safety; beh syndrome; baseline; safety apremilast ... See more keywords
Real‐world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.16439
Abstract: Little has been published on the real‐world effectiveness and safety of apremilast in psoriasis. read more here.
Keywords: real world; effectiveness safety; safety apremilast; world effectiveness ... See more keywords
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.18689
Abstract: Manifestations of psoriasis in special areas are difficult to treat and are associated with a high disease burden and significant quality of life (QoL) impairment. Topical therapies may be inadequate for these patients, necessitating systemic… read more here.
Keywords: safety apremilast; psoriasis special; efficacy safety; quality life ... See more keywords